This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Green, K. A.
Right arrow Articles by Green, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Green, K. A.
Right arrow Articles by Green, W. R.

 Previous Article  |  Next Article 

Journal of Virology, March 2008, p. 2456-2469, Vol. 82, No. 5
0022-538X/08/$08.00+0     doi:10.1128/JVI.01665-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

The Programmed Death-1 and Interleukin-10 Pathways Play a Down-Modulatory Role in LP-BM5 Retrovirus-Induced Murine Immunodeficiency Syndrome{triangledown}

Kathy A. Green,1 Taku Okazaki,2 Tasuku Honjo,2 W. James Cook,1,{dagger} and William R. Green1*

Department of Microbiology and Immunology, Dartmouth Medical School, and Norris Cotton Cancer Center, Lebanon, New Hampshire 03756,1 Department of Immunology and Genomic Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe, Sakyo-ku, Kyoto 606-8501, Japan2

Received 31 July 2007/ Accepted 11 December 2007

Pathology due to the immune system's response to viral infections often represents a delicate balance between inhibition of viral pathogenesis and regulation of protective immunity. In susceptible C57BL/6 (B6) mice, the murine retroviral isolate LP-BM5 induces splenomegaly, hypergammaglobulinemia, profound B- and T-cell immunodeficiency, and increased susceptibility to opportunistic pathogens and terminal B-cell lymphomas. Here, we report that B6.PD-1 (programmed death-1) and B6.IL-10 knockout mice are substantially more susceptible to LP-BM5-induced disease than wild-type B6 mice. LP-BM5-infected B6.PD-1–/– mice developed more severe splenomegaly, hypergammaglobulinemia, and immunodeficiency than infected B6 mice: PD-1–/– mice are more susceptible to lower doses of LP-BM5 and show more exaggerated disease early postinfection. LP-BM5-infected B6.IL-10–/– mice also develop exaggerated LP-BM5-induced disease, compared to B6 mice, without a significant change in the retroviral load. By reciprocal reconstitution experiments, comparing wild-type versus PD-1–/– sources of the requisite cells for LP-BM5 pathogenesis—CD4 T and B cells, PD-1+ B cells appear to be crucial in the normal limitation of LP-BM5-induced disease in B6 mice. Also, infected B6 mice have increased CD11b+ spleen cells that express interleukin-10 (IL-10). However, PD-1–/– mice, though showing an even greater expansion of CD11b+ cells after LP-BM5 inoculation, did not show an equivalent increase in IL-10-producing cells. Thus, it appears that PD-1/PD-L interactions and IL-10 are primarily important in moderating the effects of LP-BM5-induced disease in B6 mice.


* Corresponding author. Mailing address: Department of Microbiology and Immunology, Dartmouth Medical School, 1 Medical Center Drive, Lebanon, NH 03756. Phone: (603) 650-5056. Fax: (603) 650-6223. E-mail: kathy.a.green{at}dartmouth.edu

{triangledown} Published ahead of print on 19 December 2007.

{dagger} Present address: GlycoFi/Merck & Co., Inc., Lebanon, NH 03766.


Journal of Virology, March 2008, p. 2456-2469, Vol. 82, No. 5
0022-538X/08/$08.00+0     doi:10.1128/JVI.01665-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.